• Rebeca González González, Javier Jacob, Òscar Miró, Pere Llorens, Sònia Jiménez, Juan González Del Castillo, Guillermo Burillo-Putze, Alfonso Martín, Francisco J Martín-Sánchez, Jorge G Lamberechts, Aitor Alquézar-Arbé, Leopoldo Higa-Sansone, Sara Gayoso Martín, Virginia Carbajosa, Fahd Beddar Chaib, Manuel Salido, María J Marchena González, Ricardo Calvo López, Félix González Martínez, José Pavón Monzo, Desiré M Velarde Herrera, Ana P Niembro Valdés, Eva Quero Motto, José M Ferreras Amez, Pascual Piñera-Salmerón, and Spanish Investigators on Emergency Situations TeAm (SIESTA) Network.
• Emergency Department, Severo Ochoa University Hospital in Leganés.
• J. Clin. Gastroenterol. 2020 Nov 25.

ObjectiveThe authors investigated the incidence, risk factors, clinical characteristics, and outcomes of upper gastrointestinal bleeding (UGB) in patients with coronavirus disease 2019 (COVID-19), who were attending the emergency department (ED), before hospitalization.MethodsWe retrospectively reviewed all COVID-19 patients diagnosed with UGB in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We formed 2 control groups: COVID-19 patients without UGB (control group A) and non-COVID-19 patients with UGB (control group B). Fifty-three independent variables and 4 outcomes were compared between cases and controls.ResultsWe identified 83 UGB in 74,814 patients with COVID-19 who were attending EDs (1.11%, 95% CI=0.88-1.38). This incidence was lower compared with non-COVID-19 patients [2474/1,388,879, 1.78%, 95% confidence interval (CI)=1.71-1.85; odds ratio (OR)=0.62; 95% CI=0.50-0.77]. Clinical characteristics associated with a higher risk of COVID-19 patients presenting with UGB were abdominal pain, vomiting, hematemesis, dyspnea, expectoration, melena, fever, cough, chest pain, and dysgeusia. Compared with non-COVID-19 patients with UGB, COVID-19 patients with UGB more frequently had fever, cough, expectoration, dyspnea, abdominal pain, diarrhea, interstitial lung infiltrates, and ground-glass lung opacities. They underwent fewer endoscopies in the ED (although diagnoses did not differ between cases and control group B) and less endoscopic treatment. After adjustment for age and sex, cases showed a higher in-hospital all-cause mortality than control group B (OR=2.05, 95% CI=1.09-3.86) but not control group A (OR=1.14, 95% CI=0.59-2.19) patients.ConclusionsThe incidence of UGB in COVID-19 patients attending EDs was lower compared with non-COVID-19 patients. Digestive symptoms predominated over respiratory symptoms, and COVID-19 patients with UGB underwent fewer gastroscopies and endoscopic treatments than the general population with UGB. In-hospital mortality in COVID-19 patients with UGB was increased compared with non-COVID patients with UGB, but not compared with the remaining COVID-19 patients.

11 keywords...

hide…